kh617
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2023 (NCT05667194)
Timeline
Indications
Studied for
Mechanism of action
- Hepatocyte growth factor receptorINHIBITOR
MET inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07138001 | Phase 2 | Aug 31, 2025 | Capital Medical University, Government of China |
| NCT05667194 | Phase 1 | Dec 31, 2023 | Capital Medical University, Government of China |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 2 | 0 | 2 | 2023 |
| Government of China | Government | 2 | 2 | 2 | 2023 |
2 organizations
Page 1 / 1